Tesamorelin (10mg)

Precision-engineered peptide for growth hormone–releasing research applications.

• Tesamorelin is a stabilized analog of growth hormone–releasing hormone (GHRH 1–44) designed for controlled laboratory studies.
• Explored in research for its effects on growth hormone regulation, IGF-1 signaling, and metabolic modulation.
• Each batch independently verified for purity, identity, and sequence integrity by Vanguard Laboratory.

Tesamorelin (TH9507) is a synthetic peptide analog of human growth hormone–releasing factor (GHRH). It has been investigated in laboratory and clinical settings for its role in modulating pituitary GH secretion and IGF-1 release

Studies show Tesamorelin binds to GHRH receptors in pituitary cells, stimulating endogenous growth hormone release in a pulsatile manner and influencing lipid metabolism under experimental conditions

Additional research explores Tesamorelin’s potential metabolic and endocrine applications in pre-clinical environments

Regulatory Status: Tesamorelin is not FDA-approved for human or veterinary use. This compound is provided strictly for laboratory research applications.